Cornu M, Yang JY, Jaccard E, Poussin C, Widmann C, Thorens B
2g,h), glucagon infusions at any dose failed to significantly stimulate secretion of somatostatin, indicating that glucagon-induced somatostatin secretion depends on both glucagon and GLP-1 receptors, consistent with the finding that glucagon interacts with both receptors [14, 28]
These side effects are generally mild and temporary, often improving as your body gets used to the medication
If a rash persists, spreads, or comes with swelling, see a dermatologist to rule out allergic contact dermatitis
While tirzepatide has produced greater average weight loss in clinical trials, orforglipron offers something many people have been waiting for: a daily GLP-1 pill that doesnt require injections or special timing around meals